Lv1
40 积分 2022-08-22 加入
Unusual glycosylation of proteins: Beyond the universal sequon and other amino acids
3天前
已完结
The present and future of bispecific antibodies for cancer therapy
3天前
已完结
Development of imaged capillary isoelectric focusing as a platform mispairing byproduct testing method for asymmetric WuXiBody-based bispecific antibodies
1个月前
已完结
Particles in Biopharmaceutical Formulations, Part 2: An Update on Analytical Techniques and Applications for Therapeutic Proteins, Viruses, Vaccines and Cells
2个月前
已完结
Biparatopic antibodies: therapeutic applications and prospects
2个月前
已完结
Structure-Function Relationships for Recombinant Erythropoietins: A Case Study From a Proposed Manufacturing Change With Implications for Erythropoietin Biosimilar Study Designs
3个月前
已完结
End‐to‐end continuous bioprocessing: Impact on facility design, cost of goods, and cost of development for monoclonal antibodies
4个月前
已完结
Continuous integrated manufacturing for biopharmaceuticals: A new paradigm or an empty promise?
4个月前
已完结
Unlocking the potential of bispecific ADCs for targeted cancer therapy
4个月前
已完结
ANTIBODY CO-FORMULATION TOOLBOX AND CAPABILITIES ESTABLISHED IN WUXI BIOLOGICS
8个月前
已完结
皖公网安备34019202002308
